LexaGene Discusses The Company’s 2020 Commercialization Strategy with The Stock Day Podcast

Jan 28, 02:00 PM
The Stock Day Podcast welcomed LexaGene Holdings Inc. (LXXGF)(“the Company”), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diagnostics, food safety and for use in open-access markets such as clinical research, agricultural testing and biodefense. CEO and Founder of the Company, Dr. Jack Regan, joined Stock Day host Everett Jolly.